EVOLUÇÃO DOS TRATAMENTOS PARA DOENÇA PULMONAR OBSTRUTIVA CRÔNICA
PDF (Português (Brasil))

Keywords

DPOC
qualidade de vida
Broncodilatadores

How to Cite

Buzske Freire, J., Dias Lopes Matias, F., Silva de Almeida, M., Atalia Silva de Jesus, Y., Gabriely Silva Aguiar, E., De Sousa Coelho , E., Rafaela Morais de Menezes, C., Mayane Bezerra Aragão dos Santos, E., de Mesquita Azevedo, V., Marisa Chaves de Carvalho , K., Pablo Costa de Oliveira, J., Luzia Gamboa Souza, N., Silva, G. leite da, do Nascimento de Sousa Sena, J., Laysa Holanda Martins, S., Lima Barros, L., Geraldo Farias Lima, A., Lorena Gonçalves de Souza, J., Claudino Melo, J. A., & Santos, A. S. dos. (2024). EVOLUÇÃO DOS TRATAMENTOS PARA DOENÇA PULMONAR OBSTRUTIVA CRÔNICA. Brazilian Journal of Implantology and Health Sciences, 6(10), 2881–2888. https://doi.org/10.36557/2674-8169.2024v6n10p2881-2888

Abstract

Introduction: Chronic Obstructive Pulmonary Disease (COPD) affects millions of people worldwide and is characterized by progressive and irreversible airflow limitation. Its main manifestations include chronic bronchitis and emphysema, which negatively impact patients' quality of life. Objective: To analyze the therapeutic advances in the treatment of COPD and identify persistent challenges in disease management. Methodology: A literature review was conducted using databases such as Google Scholar, LILACS, and PubMed, employing descriptors such as "COPD treatment," "bronchodilators," "corticosteroids," and "biological therapy." Studies published between 2019 and 2024, focused on therapies for COPD, were included. Results: Long-acting bronchodilators and inhaled corticosteroids have shown effectiveness in reducing exacerbations and improving lung function. Combination therapies, such as LABA/LAMA and LABA/ICS, stand out in managing severe patients. Emerging biological therapies and non-pharmacological interventions, such as pulmonary rehabilitation and oxygen therapy, complement treatments, providing better disease control. Conclusion: Advances in COPD treatment have improved patients' quality of life, although there is a need to develop more personalized and effective approaches to optimize outcomes. 

 

https://doi.org/10.36557/2674-8169.2024v6n10p2881-2888
PDF (Português (Brasil))

References

BARNES, P. J. Inhaled corticosteroids in asthma: pharmacology and efficacy. Respiratory Care, v. 55, n. 5, p. 646-652, 2010.

CELL, B. R.; MACNEE, W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. European Respiratory Journal, v. 23, n. 6, p. 932-946, 2004.

DA SILVA CAMPOS, Hisbello. Microbioma e doença pulmonar obstrutiva crônica. Medicina, Ciência e Arte, v. 1, n. 4, p. 74-85, 2022.

DE ARAÚJO, Wattusy Estefane Cunha; DE MELO BARBOSA, Aurélio. Eficácia e segurança de tripla terapia broncodilatadora comparada à dupla terapia em DPOC grave: revisão rápida de evidências. REVISTA CIENTÍFICA DA ESCOLA ESTADUAL DE SAÚDE PÚBLICA DE GOIÁS" C NDIDO SANTIAGO", v. 8, p. 1-18 e80001, 2022.

GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD. 2023.

MAIA, Adryele Gomes et al. Análise da sobrevida em pacientes com DPOC após episódios recorrentes de exacerbação: estratégias de manejo e prevenção. Revista Coopex., v. 13, n. 2, p. 135-146, 2022.

MONTEIRO, João G. et al. Mindfulness e meditação: Práticas complementares ao tratamento do paciente com DPOC. Brazilian Journal of Health and Biomedical Sciences, v. 18, n. 1, p. 41-46, 2019.

NETO, Estenio Lopes et al. Abordagem ao paciente com doença pulmonar obstrutiva crônica (DPOC) e comorbidades cardiovasculares. Brazilian Journal of Implantology and Health Sciences, v. 6, n. 9, p. 850-867, 2024.

NOBRE, Paulo Vytor Cardoso et al. Doença pulmonar obstrutiva crônica: fatores de risco, exacerbações e implicações terapêuticas. Brazilian Journal of Implantology and Health Sciences, v. 6, n. 4, p. 2311-2321, 2024.

PEREIRA, Eanes Delgado Barros; CAVALCANTE, Antonio George de Matos. Não basta a prescrição: a importância da adesão ao tratamento farmacológico na DPOC. Jornal Brasileiro de Pneumologia, v. 48, p. e20220058, 2022.

REIS, Luiza Alves Guerra Scarpelli et al. Doença Pulmonar Obstrutiva Crônica: uma revisão de literatura. Brazilian Journal of Health and Biological Science, v. 1, n. 1, p. e35-e35, 2024.

SILVA, Ana Luiza Regina Maria Fonseca et al. Terapias inovadoras para doenças respiratórias crônicas: novas fronteiras no tratamento e gestão. Brazilian Journal of Health and Biological Science, v. 1, n. 1, p. e9-e9, 2024.

SIMÕES, Pedro Raydan Brandão et al. MANEJO ATUAL DA DOENÇA PULMONAR OBSTRUTIVA CRÔNICA: ABORDAGENSTERAPÊUTICAS E NOVAS PERSPECTIVAS. RCMOS-Revista Científica Multidisciplinar O Saber, v. 1, n. 1, 2024.

SORIANO, J. B. et al. Impact of COPD on health-related quality of life in the ECLIPSE cohort. Respiratory Medicine, v. 104, n. 12, p. 1859-1868, 2010.

VESTBO, J. et al. Global strategy for the prevention, diagnosis, and management of COPD: the GOLD science committee report. European Respiratory Journal, v. 43, n. 1, p. 144-158, 2013.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Jackeline Buzske Freire, Fabiana Dias Lopes Matias, Mayara Silva de Almeida, Yasmine Atalia Silva de Jesus, Emilly Gabriely Silva Aguiar, Elenilda De Sousa Coelho , Cassia Rafaela Morais de Menezes, Ellen Mayane Bezerra Aragão dos Santos, Vanessa de Mesquita Azevedo, Kivia Marisa Chaves de Carvalho , Juan Pablo Costa de Oliveira, Nelia Luzia Gamboa Souza, Gardênia leite da Silva, Joanderson do Nascimento de Sousa Sena, Sarah Laysa Holanda Martins, Luana Lima Barros, Antônio Geraldo Farias Lima, Jéssica Lorena Gonçalves de Souza, João Antônio Claudino Melo, Anauel Sousa dos Santos

Downloads

Download data is not yet available.